Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Protein Sciences Corporation 

1000 Research Parkway

Meriden  Connecticut  06450  U.S.A.
Phone: 203-686-0800 Fax: 203-686-0268



 Company News
Protein Sciences Corporation Expects To Begin Testing Ebola Vaccine 10/27/2014 3:18:30 PM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014 10:13:35 AM
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014 7:43:53 AM
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014 8:12:53 AM
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014 9:32:40 AM
Protein Sciences Corporation And Partners Launch Health-At-Work To Bring Flublok® And Other Vaccines To The Workplace 7/17/2014 9:56:31 AM
Protein Sciences Corporation Receives Approval From FDA For 2014/15 Formulation Of Flublok® Influenza Vaccine 7/8/2014 10:46:04 AM
U.S. Biomedical Advanced Research And Development Authority (BARDA) Extends Contract With Protein Sciences Corporation 6/18/2014 10:35:11 AM
Protein Sciences Corporation Partners File For Marketing Approval Of Flublok® Influenza Vaccine In Japan 6/2/2014 8:15:23 AM